Latest News

All the news from Anaphylaxis UK

Looking for Allergy Alerts?

Allergy Alerts

Latest News from Anaphylaxis UK

ALP Nuneaton celebrates fourth consecutive Anaphylaxis UK Allergy Aware School Award 24th March 2026

Last month, Anaphylaxis UK and Jodie Gosling, MP for Nuneaton, visited ALP Nuneaton Specialist Independent School to celebrate staff and pupils after the school achieved the Anaphylaxis UK Allergy Aware School Award for the fourth consecutive year.  Around 8% of school children
[…]

Read more
Historic Commons announcement puts children’s allergy safety on a legal footing 11th March 2026

Press release shared on behalf of the National Allergy Strategy Group, of which Anaphylaxis UK is a member The National Allergy Strategy Group (NASG) welcomes last night’s House of Commons debate, in which the Parliamentary Under-Secretary of State for Education,
[…]

Read more
Why allergy awareness matters in healthcare 9th March 2026

Allergies can impact almost every aspect of daily life — from school and travel to attending a hospital appointment. That is why Anaphylaxis UK advocates for a safer, allergy-aware approach across all environments. In healthcare settings, it may be assumed
[…]

Read more

News Type:

Meeting the Challenges of the National Allergy Crisis report 1st November 2021

The All Party Parliamentary Group for Allergy in conjunction with the National Allergy Strategy Group (NASG) has launched a report “Meeting the Challenges of the National Allergy Crisis” which calls for an influential lead for allergy to be appointed who

Read more
All Party Parliamentary Group for Allergy launch new report on the “National Allergy Crisis” 28th October 2021

The All Party Parliamentary Group for Allergy in conjunction with the National Allergy Strategy Group (NASG) are today launching a report “Meeting the Challenges of the National Allergy Crisis” which calls for an influential lead for allergy to be appointed

Read more
Anaphylaxis Campaign welcomes Simon Williams as new Chief Executive 18th October 2021

Anaphylaxis Campaign is pleased to announce the appointment of Simon Williams as CEO, as of 22 November 2021.   Simon succeeds Lynne Regent, who retired in August 2021 after 13 years as Chief Executive. Simon was Head of External Affairs

Read more
Statement regarding the inquest of Cason Hallwood 15th October 2021

The senior coroner for Cheshire, Alan Moore, has ended the inquest into the death of 12-year-old Cason Hallwood, who tragically died on Christmas Day 2020. Cason was allergic to nuts and had asthma. He died in hospital following an allergic

Read more
Anaphylaxis Campaign at the BSACI Conference 2021 14th October 2021

The Anaphylaxis Campaign was delighted to attend the annual conference of the British Society for Allergy and Clinical Immunology in Harrogate from the 6th to 9th October 2021 This was the first face-to-face conference for the BSACI in two years

Read more
Imperial College London – Short Courses in Allergy 14th October 2021

At Imperial College London, our courses are run by world-leading experts and incorporate up-to-the-minute information on new research and clinical practice to ensure that what you learn is always relevant to what you do. These innovative online courses will give

Read more
2021 vaccine recommendations for children with food allergy or asthma 14th October 2021

The paediatric allergy group of the British Society for Allergy and Clinical Immunology have produced updated guidance for clinicians about vaccinations against COVID-19, Influenza and MMR for children with food allergy or asthma. You can read the new guidance here 

Read more
New BSACI 2021 guideline for the management of egg allergy 14th October 2021

Egg allergy most commonly presents in infancy and around 1 in 50 children has an egg allergy. An updated guideline for the management of egg allergy has been announced by the British Society for Allergy and Clinical Immunology (BSACI). The

Read more
Research on the economic burden caused by peanut allergy 12th October 2021

Kantar Health, an independent research agency, is collaborating with sponsoring company DBV Technologies, and with the assistance of Anaphylaxis Campaign, to conduct research on the economic burden caused by peanut allergy. In this context, Kantar Health  invite you to participate

Read more